Findings

What do systematic reviews say?

676 questions · 705 findings · 98 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 183 · 26%GRADE not reported 47 · 6.7%Very low 209 · 29.6%Low 153 · 21.7%Moderate 85 · 12.1%High 28 · 4%

Intervention not reported

Adverse events ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Pain ‐ not reported · patients with chronic (>6 months) lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Disabilty ‐ not measured · patients with chronic (>6 months) lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Adverse events ‐ not measured · patients with chronic (>6 months) lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Disability DASH scale. Scale from: 0 to 100. ( · patients with chronic (>12 months) lateral elbow pain

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 47 participants
Low

Intervention not reported

Adverse events ‐ not measured · patients with chronic (>12 months) lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Pain‐ short term VAS scale. Scale from: 0 to 10. ( · patients with lateral elbow pain

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 24 participants
Moderate

Intervention not reported

Pain‐ long term VAS. Scale from: 0 to 10. ( · patients with lateral elbow pain

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 24 participants
Low

Intervention not reported

Disability Mayo Elbow Performance. Scale from: 0 to 100. ( · patients with lateral elbow pain

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 24 participants
Low

Intervention not reported

Adverse events ‐ not reported · patients with lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Pain ‐ not reported · patients with chronic (mean 23 months) lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Disability ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for lateral elbow pain 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any CNTF vs placebo

Deaths · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease

Any CNTF showed no clear difference in deaths compared with placebo (high certainty).

1 finding from 1 review

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease 2004 · Cochrane Headline outcomes only
RR 1.07 [0.81, 1.41]
2 studies · 1300 participants
High

Any CNTF vs placebo

Muscle strength · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease

1 finding from 1 review

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease 2004 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1300 participants
High

Any CNTF vs placebo

FVC (% predicted) Change from baseline · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease

1 finding from 1 review

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease 2004 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1300 participants
High

Changes in quality of life (SIP) change in Sickness Impact Profile (SIP) scores (range from 0 = best health to 100 = worst health). · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease

1 finding from 1 review

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease 2004 · Cochrane Headline outcomes only
no estimate extracted
1 study · 503 participants
High

Any CNTF vs placebo

Asthenia · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease

Any CNTF showed no clear difference in asthenia compared with placebo (high certainty).

1 finding from 1 review

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease 2004 · Cochrane Headline outcomes only
RR 1.02 [0.81, 1.28]
1 study · 570 participants
High

Any CNTF vs placebo

Nausea · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease

Any CNTF showed no clear difference in nausea compared with placebo (high certainty).

1 finding from 1 review

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease 2004 · Cochrane Headline outcomes only
RR 1.35 [0.92, 1.99]
1 study · 570 participants
High

Any CNTF vs placebo

Increased salivation · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease

Any CNTF showed no clear difference in increased salivation compared with placebo (high certainty).

1 finding from 1 review

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease 2004 · Cochrane Headline outcomes only
RR 1.08 [0.78, 1.5]
1 study · 570 participants
High

Hyperbaric oxygen vs control without HBOT

Death at 1 year · any person with radiation tissue injury arising later than 6 months after irradiation (LRTI), including dysfunction or necrosis of any…

Hyperbaric oxygen therapy (HBOT) showed no clear difference in death at 1 year compared with control without HBOT (low certainty).

1 finding from 1 review

Hyperbaric oxygen therapy for late radiation tissue injury 2023 · Cochrane Headline outcomes only
RR 0.93 [0.47, 1.83]
3 studies · 166 participants
Low